Neuphoria Therapeutics Inc. (NEUP)
NASDAQ: NEUP · Real-Time Price · USD
4.880
-0.170 (-3.37%)
At close: Feb 21, 2025, 4:00 PM
4.990
+0.110 (2.25%)
After-hours: Feb 21, 2025, 5:22 PM EST
Neuphoria Therapeutics Market Cap
Neuphoria Therapeutics has a market cap or net worth of $8.57 million as of February 21, 2025.
Market Cap
8.57M
Enterprise Value
4.40M
1-Year Change
n/a
Ranking
Category
Stock Price
$4.88
Market Cap Chart
Since December 24, 2024, Neuphoria Therapeutics's market cap has decreased from $10.79M to $8.57M, a decrease of -20.53%. That is a compound annual growth rate of -75.86%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 21, 2025 | 8.57M | 53.62% |
| Dec 31, 2024 | 5.58M | -48.27% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 784.71B |
| UnitedHealth Group | 429.24B |
| Novo Nordisk | 391.83B |
| Johnson & Johnson | 390.92B |
| AbbVie | 356.74B |
| Abbott Laboratories | 234.01B |
| AstraZeneca | 229.50B |
| Merck & Co. | 226.40B |